General Western Blot Reagents
Abcam gamma-DGG (gamma-D-Glutamylglycine) (mM/ml), Ionotropic glutamate antagonist, 100MM_ML
MW 204.18 Da, Purity >99%. Ionotropic glutamate receptor antagonist that has been used as a rapidly dissociating, low affinity competitive antagonist at AMPA receptors.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Dansyl chloride, Fluorogenic primary amine reactive reagent, 5G
MW 269.75 g/mol, Purity >95%. Fluorogenic primary amine reactive reagent for N-terminal derivatization of amino acids and peptides, and for polyamine detection by reverse phase HPLC and other analytical procedures. Fluorescence: λex 337 nm; λem 492 nm in chloroform (after derivatization with hexylamine).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human coronavirus SARS-CoV-2 envelope protein peptide, 50UG
Human coronavirus SARS-CoV-2 envelope protein peptide is a Synthetic blocking peptide. Suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: sM, 4, E, Envelope small membrane protein, E protein, sM protein
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Mouse EGFR peptide, 1MG
Mouse EGFR peptide is a Synthetic blocking peptide. >90% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: ERBB, ERBB1, HER1, EGFR, Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam D-(+)-Galactose, C-4 epimer of glucose, 25G
MW 180.16 g/mol, Purity >98%. C-4 epimer of glucose. Aldohexose that serves as an energy source and as an essential component of glycolipids and glycoproteins.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bis(3,5-dibromosalicyl) fumarate, hemoglobin acylating agent, 500MG
MW 671.9 Da, Purity >93%. Potent hemoglobin acylating agent. Cross-links beta chains of hemoglobin. Acylating and anti-sickling agent. Active in vitro and in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Carbo x y-DCFDA N-succinimidyl ester, Fluorogenic esterase substrate, 250MG
MW 626.35 g/mol, Purity >96%. Cell-permeable, fluorogenic esterase substrate. Becomes hydrolyzed intracellularly to green fluorophore DCFA (ab145439) and covalently bonds to proteins.
The product is subject to the following: Abcam Restricted Use Statement
Abcam UNC669, L3MBTL antagonist, 25MG
MW 338.25 g/mol, Purity >99%. Selective, competitive L3MBTL antagonist (IC₅₀ = 5 μM). Inhibits L3MBTL induced transcription repression. Active in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam L-Leucine 7-amido-4-methylcoumarin, Fluorogenic substrate, 250MG
MW 288.37 g/mol, Purity >98%. Sensitive fluorogenic substrate for leucine aminopeptidase and aminopeptidase M. The release of fluorescent 7-amino-4-methylcoumarin can be measured. Hydrolysis rates can be measured using either a continuous or stopped assay.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Rosiglitazone potassium salt, PPARgamma agonist, 10MG
MW 395.5 Da, Purity >99%. Potent, selective PPARγ agonist (Kd = 43 nM, PPARγ ligand binding domain). Activates PPARγ expression (EC₅₀ = 1 μM). Shows antidiabetic and hypoglycemic effects in vivo. Orally active. Water soluble.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ingenol-3-angelate, PKC activator, 5MG
MW 430.5 Da, Purity >98%. Selective activator of PKC isoforms, like PKCθ in T cells. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 6-IAF (6-Iodoacetamidofluorescein), Thiol-reactive fluorescent label, 250MG
MW 515.3 Da, Purity >95%. Thiol-reactive fluorescent label. Acts as an acceptor fluorophore in FRET studies with excitation and emission maxima of 347 and 530 nm respectively. 6-IATR (ab145010) derivative. Labels actin, microtubule-associated proteins and histones.
The product is subject to the following: Abcam Restricted Use Statement
Abcam N-Palmitoyl phosphatidylethanolamine, Endogenous lipid anorectic hormone, 1MG
MW 930.4 g/mol, Purity >98%. Endogenous lipid which significantly reduced food intake in a dose-dependent fashion when administered to rats and mice without causing taste aversion. Found to enter the brain (concentrating in the hypothalamus) when administered systemically and also reduced food intake when infused intracerebroventricularly (nanomolar concentrations), suggesting that mediation of effects is via the CNS. Chronic infusion resulted in a reduction of both food intake and body weight, suggesting that NAPE and long-acting NAPE analogs may be novel therapeutic targets for the treatment of obesity.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 680C91, tryptophan 2,3-dio x ygenase inhibitor, 5MG
MW 238.26 Da. Potent, selective, substrate competitive tryptophan 2,3-dioxygenase inhibitor (Ki = 51 nM). Inhibits tryptophan catabolism. Increases brain tryptophan and serotonin levels in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam L-Mimosine, non-protein amino acid, 25MG
MW 198.18 g/mol, Purity >98%. Toxic non-protein amino acid originally isolated from Mimosa pudica. Arrests the cell cycle at the G1 phase in PC-3 cells and at the S phase in LNCaP cells, thus attenuating cell proliferation. Blocks cell cycle progression by chelating iron in asynchronous MDA-MB-453 human breast cancer cells. Arrests DNA synthesis by inhibiting deoxyribonucleotide metabolism. Prolyl hydroxylase (PHD) inhibitor stimulating VEGF production, and increasing proangiogenic capacity in dental pulp-derived cells.
The product is subject to the following: Abcam Restricted Use Statement